These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 35894054)

  • 41. Human risk allele HLA-DRB1*0405 predisposes class II transgenic Ab0 NOD mice to autoimmune pancreatitis.
    Freitag TL; Cham C; Sung HH; Beilhack GF; Durinovic-Belló I; Patel SD; Bronson RT; Schuppan D; Sønderstrup G
    Gastroenterology; 2010 Jul; 139(1):281-91. PubMed ID: 20303356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of HLA-DQ and HLA-DR alleles with susceptibility or resistance to HIV-1 infection among the population of Chaco Province, Argentina.
    Motta P; Marinic K; Sorrentino A; López R; Iliovich E; Habegger de Sorrentino A
    Medicina (B Aires); 2002; 62(3):245-8. PubMed ID: 12150008
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HLA class II haplotype DRB1*04-DQB1*0301 contributes to risk of familial generalized vitiligo and early disease onset.
    Fain PR; Babu SR; Bennett DC; Spritz RA
    Pigment Cell Res; 2006 Feb; 19(1):51-7. PubMed ID: 16420246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.
    Ito K; Bian HJ; Molina M; Han J; Magram J; Saar E; Belunis C; Bolin DR; Arceo R; Campbell R; Falcioni F; Vidović D; Hammer J; Nagy ZA
    J Exp Med; 1996 Jun; 183(6):2635-44. PubMed ID: 8676084
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HLA class II associations with rheumatic heart disease among clinically homogeneous patients in children in Latvia.
    Stanevicha V; Eglite J; Sochnevs A; Gardovska D; Zavadska D; Shantere R
    Arthritis Res Ther; 2003; 5(6):R340-6. PubMed ID: 14680508
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis.
    Laivoranta-Nyman S; Möttönen T; Hermann R; Tuokko J; Luukkainen R; Hakala M; Hannonen P; Korpela M; Yli-Kerttula U; Toivanen A; Ilonen J;
    Ann Rheum Dis; 2004 Nov; 63(11):1406-12. PubMed ID: 15479890
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of HLA-restricted EBV-specific cytotoxic T cells does not require CD4+ (helper) T cells or exogenous cytokines.
    Fishwild DM; Benike CJ; Engleman EG
    J Immunol; 1988 Mar; 140(6):1994-8. PubMed ID: 2831276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population.
    Petrone A; Giorgi G; Mesturino CA; Capizzi M; Cascino I; Nistico L; Osborn J; Di Mario U; Buzzetti R
    Thyroid; 2001 Feb; 11(2):171-5. PubMed ID: 11288988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Although DR3-DQB1*0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1*0302 haplotype is implicated only in beta-cell autoimmunity.
    Huang W; Connor E; Rosa TD; Muir A; Schatz D; Silverstein J; Crockett S; She JX; Maclaren NK
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2559-63. PubMed ID: 8675578
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective T cell receptor Vbeta gene usage by alloreactive T cells responding to defined HLA-DR alleles.
    Lobashevsky A; Kotb M; Gaber AO
    Transplantation; 1996 Nov; 62(9):1332-40. PubMed ID: 8932281
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HLA-DQA1 and DQB1 allele and genotype contribution to IDDM susceptibility in an ethnically mixed population.
    Balducci-Silano PL; Layrisse Z; Dominguez E; Amaro R; Gunczler P; Lanes R; Zaro R
    Eur J Immunogenet; 1994 Dec; 21(6):405-14. PubMed ID: 9098450
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA typing of HLA class II genes in Japanese patients with dilated cardiomyopathy.
    Nishi H; Koga Y; Koyanagi T; Harada H; Imaizumi T; Toshima H; Sasazuki T; Kimura A
    J Mol Cell Cardiol; 1995 Oct; 27(10):2385-92. PubMed ID: 8576952
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles.
    Allen M; Sandberg-Wollheim M; Sjögren K; Erlich HA; Petterson U; Gyllensten U
    Hum Immunol; 1994 Jan; 39(1):41-8. PubMed ID: 8181961
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Associations of HLA-DRB1, DQB1 and DPB1 alleles with pulmonary tuberculosis in south India.
    Ravikumar M; Dheenadhayalan V; Rajaram K; Lakshmi SS; Kumaran PP; Paramasivan CN; Balakrishnan K; Pitchappan RM
    Tuber Lung Dis; 1999; 79(5):309-17. PubMed ID: 10707259
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.
    Murray RJ; Kurilla MG; Brooks JM; Thomas WA; Rowe M; Kieff E; Rickinson AB
    J Exp Med; 1992 Jul; 176(1):157-68. PubMed ID: 1319456
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HLA class II immunogenetics of IDDM in Yemenite Jews.
    Israel S; Kwon OJ; Weintrob N; Sprecher E; Bloch K; Assa S; Brautbar C; Vardi P
    Hum Immunol; 1998 Nov; 59(11):728-33. PubMed ID: 9796741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population.
    Saito S; Ota S; Yamada E; Inoko H; Ota M
    Tissue Antigens; 2000 Dec; 56(6):522-9. PubMed ID: 11169242
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses.
    Ferre AL; Hunt PW; McConnell DH; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL
    J Virol; 2010 Nov; 84(21):11020-9. PubMed ID: 20719952
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human leukocyte antigen class II alleles and risk of cervical cancer in China.
    Wu Y; Liu B; Lin W; Xu Y; Li L; Zhang Y; Chen S; Lin Z; Xu A
    Hum Immunol; 2007 Mar; 68(3):192-200. PubMed ID: 17349874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.